Skip to main content

and
  1. No Access

    Article

    Impact of HLA-E gene polymorphism on HLA-E expression in tumor cells and prognosis in patients with stage III colorectal cancer

    Human leukocyte antigen (HLA)-E can contribute to the escape of cancer cells from host immune mechanisms. However, it is unknown whether HLA-E gene polymorphisms might play a role in cancer immune escape. This...

    Zi-Jun Zhen, Jia-Yu Ling, Yue Cai, Wen-Biao Luo, You-Jian He in Medical Oncology (2013)

  2. No Access

    Article

    Phase II study of capecitabine plus oxaliplatin (XELOX) as first-line treatment and followed by maintenance of capecitabine in patients with metastatic colorectal cancer

    The aim of this study is to evaluate the safety and efficacy of the combination of capecitabine and oxaliplatin (XELOX) as first-line treatment in Chinese patients with metastatic colorectal carcinoma (mCRC). ...

    Yu Hong Li, Hui Yan Luo, Feng Hua Wang in Journal of Cancer Research and Clinical On… (2010)